Andorra vs Sri Lanka: Measles-containing-vaccine second-dose (MCV2) immunization coverage
Andorra
96.0%
in 2025
Sri Lanka
95.0%
in 2025
Andorra rank
26th
Sri Lanka rank
29th
Measles-containing-vaccine second-dose (MCV2) immunization coverage over time
- Andorra
- Sri Lanka
How they compare
Andorra currently reports 96.0% against 95.0% in Sri Lanka, a difference of 1.0%.
The two have swapped places 1 time across 26 shared years of data; in 2000 it was Sri Lanka ahead.
Andorra ranks 26th and Sri Lanka ranks 29th of 194 countries.
Sri Lanka has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Andorra | Sri Lanka | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 24.8% | 81.7% | 56.9% | Sri Lanka |
| 2010s | 90.2% | 99.0% | 8.8% | Sri Lanka |
| 2020s | 95.8% | 97.2% | 1.3% | Sri Lanka |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher measles-containing-vaccine second-dose (mcv2) immunization coverage, Andorra or Sri Lanka?
- Andorra, at 96.0% against 95.0% in Sri Lanka as of 2025.
- What is the difference in measles-containing-vaccine second-dose (mcv2) immunization coverage between Andorra and Sri Lanka?
- 1.0%, with Andorra ahead.
- How many years of comparable data are there for Andorra and Sri Lanka?
- 26 years are reported by both, from 2000 to 2025.
- How do Andorra and Sri Lanka rank globally for measles-containing-vaccine second-dose (mcv2) immunization coverage?
- Andorra ranks 26th and Sri Lanka ranks 29th of 194 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Measles-containing-vaccine second-dose (MCV2) immunization coverage by the locally recommended age (%) (WUENIC). Statizoid refreshes it automatically from the source and publishes the full history for both places.